FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2489339849> ?p ?o ?g. }

• W2489339849 endingPage "285" @default.
• W2489339849 startingPage "275" @default.
• W2489339849 abstract "Cystic fibrosis (CF) is caused by loss-of-function mutations of the cystic fibrosis transmembrane conductance regulator (CFTR) gene encoding a phosphorylation-activated but ATP-gated chloride channel. Previous studies suggested that VX-770 [ivacaftor, N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide], a CFTR potentiator now used in clinics, increases the open probability of CFTR by shifting the gating conformational changes to favor the open channel configuration. Recently the chloride channel blocker and CFTR potentiator 5-nitro-2-(3-phenylpropylamino) benzoate (NPPB) has been reported to enhance CFTR activity by a mechanism that exploits the ATP hydrolysis-driven, nonequilibrium gating mechanism unique to CFTR. Surprisingly however, NPPB increased the activity of nonhydrolytic G551D-CFTR, the third most common disease-associated mutation. Here, we further investigated the mechanism of NPPB's effects on CFTR gating by assessing its interaction with well-studied VX-770. Interestingly, once G551D-CFTR was maximally potentiated by VX-770, NPPB further increased its activity. However, quantitative analysis of this drug-drug interaction suggests that this pharmacologic synergism is not due to independent actions of NPPB and VX-770 on CFTR gating; instead, our data support a dependent mechanism involving two distinct binding sites. This latter idea is further supported by the observation that the locked-open time of a hydrolysis-deficient mutant K1250A was shortened by NPPB but prolonged by VX-770. In addition, the effectiveness of NPPB, but not of VX-770, was greatly diminished in a mutant whose second nucleotide-binding domain was completely removed. Interpreting these results under the framework of current understanding of CFTR gating not only reveals insights into the mechanism of action for different CFTR potentiators but also brings us one step forward to a more complete schematic for CFTR gating." @default.
• W2489339849 created "2016-08-23" @default.
• W2489339849 creator A5023257350 @default.
• W2489339849 creator A5053951611 @default.
• W2489339849 creator A5062876989 @default.
• W2489339849 date "2016-07-13" @default.
• W2489339849 modified "2023-10-12" @default.
• W2489339849 title "Synergistic Potentiation of Cystic Fibrosis Transmembrane Conductance Regulator Gating by Two Chemically Distinct Potentiators, Ivacaftor (VX-770) and 5-Nitro-2-(3-Phenylpropylamino) Benzoate" @default.
• W2489339849 cites W1524370537 @default.
• W2489339849 cites W1536768176 @default.
• W2489339849 cites W1559960422 @default.
• W2489339849 cites W1866974283 @default.
• W2489339849 cites W1973876121 @default.
• W2489339849 cites W1976197028 @default.
• W2489339849 cites W1988003798 @default.
• W2489339849 cites W1989101763 @default.
• W2489339849 cites W1991977085 @default.
• W2489339849 cites W2001846710 @default.
• W2489339849 cites W2004155358 @default.
• W2489339849 cites W2004844038 @default.
• W2489339849 cites W2005105608 @default.
• W2489339849 cites W2007762759 @default.
• W2489339849 cites W2011532795 @default.
• W2489339849 cites W2030819680 @default.
• W2489339849 cites W2035131077 @default.
• W2489339849 cites W2039413420 @default.
• W2489339849 cites W2039599894 @default.
• W2489339849 cites W2040690917 @default.
• W2489339849 cites W2041207269 @default.
• W2489339849 cites W2043524902 @default.
• W2489339849 cites W2044594872 @default.
• W2489339849 cites W2045331285 @default.
• W2489339849 cites W2047198892 @default.
• W2489339849 cites W2049914201 @default.
• W2489339849 cites W2064581901 @default.
• W2489339849 cites W2071407356 @default.
• W2489339849 cites W2078078890 @default.
• W2489339849 cites W2080281443 @default.
• W2489339849 cites W2084896237 @default.
• W2489339849 cites W2093013713 @default.
• W2489339849 cites W2096914283 @default.
• W2489339849 cites W2102781109 @default.
• W2489339849 cites W2114594888 @default.
• W2489339849 cites W2115127888 @default.
• W2489339849 cites W2121996960 @default.
• W2489339849 cites W2122131707 @default.
• W2489339849 cites W2122484880 @default.
• W2489339849 cites W2124233675 @default.
• W2489339849 cites W2124886725 @default.
• W2489339849 cites W2125129540 @default.
• W2489339849 cites W2126532539 @default.
• W2489339849 cites W2140868856 @default.
• W2489339849 cites W2141023256 @default.
• W2489339849 cites W2145786361 @default.
• W2489339849 cites W2148269714 @default.
• W2489339849 cites W2156445984 @default.
• W2489339849 cites W2161849629 @default.
• W2489339849 cites W2167724548 @default.
• W2489339849 cites W2170377964 @default.
• W2489339849 cites W2258857075 @default.
• W2489339849 cites W2326932057 @default.
• W2489339849 cites W2340515141 @default.
• W2489339849 cites W4241884576 @default.
• W2489339849 cites W4248239529 @default.
• W2489339849 doi "https://doi.org/10.1124/mol.116.104570" @default.
• W2489339849 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4998663" @default.
• W2489339849 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27413118" @default.
• W2489339849 hasPublicationYear "2016" @default.
• W2489339849 type Work @default.
• W2489339849 sameAs 2489339849 @default.
• W2489339849 citedByCount "28" @default.
• W2489339849 countsByYear W24893398492016 @default.
• W2489339849 countsByYear W24893398492017 @default.
• W2489339849 countsByYear W24893398492018 @default.
• W2489339849 countsByYear W24893398492019 @default.
• W2489339849 countsByYear W24893398492020 @default.
• W2489339849 countsByYear W24893398492021 @default.
• W2489339849 countsByYear W24893398492022 @default.
• W2489339849 countsByYear W24893398492023 @default.
• W2489339849 crossrefType "journal-article" @default.
• W2489339849 hasAuthorship W2489339849A5023257350 @default.
• W2489339849 hasAuthorship W2489339849A5053951611 @default.
• W2489339849 hasAuthorship W2489339849A5062876989 @default.
• W2489339849 hasBestOaLocation W24893398491 @default.
• W2489339849 hasConcept C104317684 @default.
• W2489339849 hasConcept C12554922 @default.
• W2489339849 hasConcept C126322002 @default.
• W2489339849 hasConcept C141315368 @default.
• W2489339849 hasConcept C145822097 @default.
• W2489339849 hasConcept C164718446 @default.
• W2489339849 hasConcept C181199279 @default.
• W2489339849 hasConcept C185592680 @default.
• W2489339849 hasConcept C194544171 @default.
• W2489339849 hasConcept C23265538 @default.
• W2489339849 hasConcept C2776502428 @default.
• W2489339849 hasConcept C2776938444 @default.
• W2489339849 hasConcept C2778428886 @default.
• W2489339849 hasConcept C55493867 @default.

• next